Accreditation Council for Continuing Medical Education. 2012. Annual Report. http://www. accme.org/sites/default/files/630_2012_Annual_Report_20130724_1.pdf. Accessed 3 Oct 2013.
Adis Communications. 2006. http://www.pharmalive.com/content/supplements/gpms/2004/adis. cfm. Accessed 20 Dec 2006.
Angell, M. 2004. The Rruth about the Drug companies: How They Deceive Us and What to Do about It. New York: Random House.
Applbaum, K. 2004. The Marketing Era: From Professional Practice to Global Provisioning. New York: Routledge.
Bohdanowicz, H. 2005, September 21. A Guide to Strategic Communication Planning. Pharmaceutical Executive Europe.
--. 2009. The Synergy of Public Relations and Medical Education. CommuniquS 24: 14-16.
Brody, H. 2007. Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry. Lanham: Rowman & Littlefield Publishers.
CampbellAlliance. 2011 Communicating the Value of Medical Affairs. Brochure for a Whitepaper. Carlat, D. 2007, Nov. 25. Dr. Drug Rep. The New York Times.
CenterWatch. 2009. State of the Clinical Trials Industry: A Sourcebook of Charts and Statistics. Boston: CenterWatch.
Envision Pharma. 2006. http://www.envisionpharma.com/publicationsPlanning/. Accessed 20 Dec 2006.
Fisher, J. 2009. Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials. New Brunswick: Rutgers University Press.
Fugh-Berman, A., and S. Ahari. 2007. Following the Script: How Drug Reps Make Friends and Influence Doctors. PLoS Medicine 4(4): e150.
Gardiner-Caldwell Group. 2007. http://www.thgc-group.com/. Accessed Nov 2007.
Gramsci, A. 1971 Selections from the Prison Notebooks of Antonio Gramsci, Eds. and trans.
Q. Hoare and G.N. Smith. New York: International.
Healy, D., and D. Cattell. 2003. Interface between Authorship, Industry and Science in the Domain of Therapeutics. The British Journal of Psychiatry 183: 22-27.
Hensley, S., and B. Martinez. 2005, July 15. New Treatment: To Sell Their Drugs, Companies Increasingly Rely on Doctors. Wall Street Journal.
ICMJE. 2014. Defining the Role of Authors and Contributors. http://www.icmje.org/recommenda- tions/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html. Accessed 30 Jan 2015.
InsiteResearch. 2008. The Prescription for KOL Management. Next Generation Pharmaceutical 12. http://www.ngpharma.com/. Accessed 28 Mar 2011.
Katz, E., and P. Lazarsfeld. 1955. Personal Influence: The Part Played by People in the Flow of Mass Communications. Glencoe: The Free Press.
KnowledgePoint360. 2010. Promotional Brochure.
Lundh, A., S. Sismondo, J. Lexchin, O. Busuioc, and L. Bero. 2012. Industry Sponsorship and Research Outcome. Cochrane Database of Systematic Reviews 12: MR000033.
Mirowski, P., and R. Van Horn. 2005. The Contract Research Organization and the Commercialization of Scientific Research. Social Studies of Science 35: 503-534.
Moynihan, R. 2008. Key Opinion Leaders: Independent Experts or Drug Representatives in Disguise. British Medical Journal 336: 1402-1403.
Oldani, M. 2004. Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices.
Medical Anthropology Quarterly 18(3): 325-356.
Petryna, A. 2009. When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton: Princeton University Press.
Reid, L., and M. Herder. 2013. The Speakers’ Bureau System: A Form of Peer Selling. Open Medicine 7(2): e31.
Ross, J.S., K.P. Hill, D.S. Egilman, and H.M. Krumholz. 2008. Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation. Journal of the American Medical Association 299(15): 1800-1812.
Shah, S. 2006. The Body Hunters: Testing New Drugs on the World’s Poorest Patients. New York: New Press.
Sismondo, S. 2007. Ghost Management: How Much of the Medical Literature is Shaped Behind the Scenes by the Pharmaceutical Industry? PLoS Medicine 4(9): e286.
--. 2009. Ghosts in the Machine: Publication Planning in the Medical Sciences. Social
Studies of Science 39(2): 171-198.
Smith, R. 2006. Lapses at the New England Journal of Medicine. Journal of the Royal Society of Medicine 99(8): 380-382.
Watermeadow Medical. 2007. http://www.watermeadowmedical.com/. Accessed 29 Nov 2007.
Wave Healthcare. 2011. KOL Training. http://www.wavehealthcare.co.uk/en/1/koltraining.html. Accessed 25 Mar 2011.
Wyeth. 2002. Publication Plan 2002—Premarin/Trimegestone HRT Working Draft. http://dida. library.ucsf.edu/tid/awb37b10. Accessed 19 Aug 2013.